Home
Search

Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases
Browse all Press Releases
BIO Statement on Proposed Rule to Implement Comprehensive Outbound Investment National Security (COINS) Act
October 22, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) rule:"The Administration is correct that biotechnology is a strategic technology industry for the…
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’
October 14, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step toward advancing regulatory approaches that better…
BIO Statement on Finalization of the Globe Model
September 30, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering medical miracles to patients, driving economic growth,…